Your browser doesn't support javascript.
loading
Medication profiling in women with type 1 diabetes highlights the importance of adequate, guideline-based treatment in low-risk groups.
Lithovius, Raija; Mutter, Stefan; Parente, Erika B; Mäkinen, Ville-Petteri; Valo, Erkka; Harjutsalo, Valma; Groop, Per-Henrik.
Afiliação
  • Lithovius R; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
  • Mutter S; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Parente EB; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Mäkinen VP; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
  • Valo E; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Harjutsalo V; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Groop PH; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Sci Rep ; 13(1): 17893, 2023 10 19.
Article em En | MEDLINE | ID: mdl-37857707
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Antagonistas de Receptores de Angiotensina Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Antagonistas de Receptores de Angiotensina Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article